Hochschulschrift
Entry and competition in the pharmaceutical market following patent expiry : evidence from macro and micro data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Univ., Diss., 2011
- Keyword
-
Generika
Pharmazeutisches Produkt
Markteintritt
Wettbewerb
Deutschland
Generikum
Impfstoff
Arzneimittel
Heilmittel
Markteintrittsstrategie
Marktzugang
Wettbewerb
Wettbewerbsfreiheit
Wettbewerbsfähigkeit
Deutschland
- Creator
- URN
-
urn:nbn:de:bvb:19-131082
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Information and competition entry
Information and Competition Entry
Does increased price competition reduce entry of new pharmaceutical products?
Exchange Competition, Entry, and Welfare
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Reputation, Competition, and Entry in Procurement
Free entry, regulatory competition, and globalization
Entry barriers, competition, and technology adoption
Market Entry Regulation and International Competition
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Oligopolistic Competition, Product Variety and Entry Deterrence
Information and competition entry
Information and Competition Entry
Does increased price competition reduce entry of new pharmaceutical products?
Exchange Competition, Entry, and Welfare
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Reputation, Competition, and Entry in Procurement
Free entry, regulatory competition, and globalization
Entry barriers, competition, and technology adoption
Market Entry Regulation and International Competition
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Oligopolistic Competition, Product Variety and Entry Deterrence
Information and competition entry
Information and Competition Entry
Does increased price competition reduce entry of new pharmaceutical products?
Exchange Competition, Entry, and Welfare
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Reputation, Competition, and Entry in Procurement
Free entry, regulatory competition, and globalization
Entry barriers, competition, and technology adoption
Market Entry Regulation and International Competition
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?